News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Soren Tulstrup to Lead Shire plc's HGT's MPS Franchise


7/31/2012 7:08:27 AM

Shire plc (LSE: SHP, NASDAQ: SHPGY), today announced the appointment of Soren Tulstrup as Senior Vice President and Franchise Lead, MPS (mucopolysaccharides) for its Human Genetic Therapies (HGT) business. In this role, Soren will be responsible for developing global strategy for the MPS franchise, which includes both commercial and pipeline products, and will play a key role in strategic decisions made about the Company's growing rare disease portfolio. He will report to Sylvie Grgoire, President of Shire HGT, and will be based in Shire's office in Nyon, Switzerland.

Read at News Release

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES